University of Rochester
Rochester, New York, 14642, United States
Location status: Recruiting
Location contact
Beau Abar
SUB_INVESTIGATOR
David Adler
PRINCIPAL_INVESTIGATOR
Nancy Wood
CONTACT
Peter MacDowell
CONTACT
NCT Number: NCT07287085
The objective of the proposed clinical trial is to determine if we can increase LCS among ED patients using a combination of facilitated referral to an LCS program plus text message reminders to get screened. Step 1 of the approach is to identify participants that are eligible for LCS. Step 2 is to randomize eligible study participants between two study arms: (1) basic referral for LCS (i.e.
verbal referral with written materials), and (2) facilitated referral for LCS (i.e. submission of a requisition to LCS program by staff) plus a subsequent series of text messages aimed at generating intention and motivation to get screened. The investigators' preliminary work showed this approach was feasible in the ED setting. The proposed study will build on this preliminary work with the goal of having a significant positive impact on LCS uptake.
A total of 300 individuals eligible for LCS will be recruited from a high-volume urban ED, randomized between study arms, and followed-up at 120 days to assess interval LCS uptake. The Specific Aims of the proposed project are, (1) Compare LCS uptake between the two study arms, (2) Identify predictors of individuals that are not up-to-date with LCS at the time of enrollment, and (3) Evaluate study participant feedback on (a) barriers and facilitators to getting screened and (b) acceptability and appropriateness of ED-based promotion of LCS. The study team is at the forefront of developing ED-based interventions to promote cancer screening. This project leverages the universal access setting of the ED to identify individuals at greatest risk for lung cancer and get them screened. A scalable ED-based intervention that increases LCS uptake would save lives.
Interested in participating?
Request Info50 year–80 year
All sexes
Interventional
Not applicable
Rochester, New York, 14642, United States
Location status: Recruiting
Beau Abar
SUB_INVESTIGATOR
David Adler
PRINCIPAL_INVESTIGATOR
Nancy Wood
CONTACT
Peter MacDowell
CONTACT
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants randomized to the experimental arm will be instructed that the LCS program will reach out to them to discuss LCS and, if decided upon, schedule screening. An LCS Program Navigator will call the participant by phone, conduct a shared decision-making discussion, and schedule the screening CT scan (assuming eligibility is confirmed and the discussion results in the participant's decision to schedule screening). In addition, participants in Arm 2 will receive a series of text messages, grounded in the TPB, SDT, and HBM aimed at generating intention and motivation to get LCS.
They will also be provided with written materials that include telephone contact information for the LCS Program Navigator. If contacted, the LCS Program Navigator will conduct a shared decision-making (SDM) discussion, schedule the screening CT scan at one of the 8 regional American College of Radiology-designated LCS centers and arrange follow-up as needed. Since determination of LCS needs is not routine during an ED visit, this "control arm" reflects an enhancement over usual care. It would not be ethical to identify a patient with screening needs without providing a referral.
Time frame: From enrollment through participation with first assessment at ~ 120 days of participation.
The primary outcome, LCS uptake, will be assessed via telephone follow-up and EHR review.
Contact information is provided by the study sponsor or research team.
University of Rochester
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06830304
Screening Compliance
Chongqing, Chongqing Municipality, China
View Trial DetailsNCT03209765
Colonic Diseases, Colorectal Cancer
Hong Kong
View Trial DetailsNCT07168993
Disease, Lung Cancer (Diagnosis)
Palo Alto, California, United States
View Trial DetailsNCT07675967
Adenocarcinoma Of Esophagus, Bone Diseases
Boston, Massachusetts, United States
View Trial Details